TP53 and cancer: p53 mutations that are also likely to result from oxidative damage during inflammation, have been detected in both, cancer cells and non-dysplastic inflamed epithelium, in colitis associated cancer, further substantiating the notion that chronic inflammation induces genomic changes (13).